CDSCO Publishes List Of Drugs Declared As Not Of Standard Quality And Spurious For June 2024
The NSQ drug list specifies a total of 30 drugs that were detected to be deficient by State Lab Drugs Control Laboratory, Telangana. All of these 30 drugs were declared to be not of standard quality and 2 were also found to be misbranded. The NSQ drug list for central CDSCO laboratories specifies a total of 31 drugs that were detected to be deficient.
Ensuring Public Health: Gujarat’s Response to the Chandipura Virus Outbreak
Recently, the Chief Minister of Gujarat undertook a comprehensive review of the ongoing Chandipura virus situation in the state. Alongside the Health Minister and senior officials, the Chief Minister utilized video conferencing to engage municipal commissioners, district collectors, district development officers, and chief district health officers.
Government Proposes New Labeling Requirements for Drugs
These draft rules propose the inclusion of “details of excipients” on all drug labels. The amendment also proposes replacing semicolons with full stops (periods) after “date of expiry” and “manufacturing license number” to improve clarity and separation of information.
Health Cards and Inspections: Kerala’s Recent Actions
In a proactive move to safeguard public health, Kerala’s Health Minister has issued a stern directive regarding the mandatory health cards for employees in food establishments across the state.
Introduction to e-Aushadhi Portal by Kerala Government
The Kerala Ayurveda Siddha Unani Medicine State Licensing Authority has issued a circular mandating that all applications for services provided by the Drugs Control Ayurveda Department, such as drug manufacturing licenses and loan licenses, must now be submitted through the e-Aushadhi Portal.
MoHFW Notifies New Draft Drug Rules (….Amendment),2024
On July 10, 2024, the Ministry of Health and Family Welfare proposed amendments to the Drugs and Cosmetics Rules, 1945, focusing on Schedule G drugs:
Rule 74: Includes Schedule G drugs in specific regulatory requirements.
Rule 74A: Adds guidelines for manufacturing and distribution of Schedule G drugs.
Rule 74B: Specifies safety measures for Schedule G drugs.
Rule 78: Strengthens oversight in licensing and registration for Schedule G drugs.
Rule 78A: Details responsibilities for manufacturers and distributors of Schedule G drugs.
Advancing Public Health: Launching E-Health at Kottayam General Hospital
As a significant step towards enhancing healthcare accessibility, Kottayam General Hospital is set to launch its e-health initiative. The inauguration ceremony is scheduled for Friday, July 12, with Trivandrum MLA presiding over the event. The district panchayat president will chair the proceedings, highlighting the collaborative effort to bring modern healthcare solutions to the community. This notification […]
Heart Defect Closure: Innovative Stent Procedure Supported by Kerala Government
Kottayam Medical College recently achieved a significant medical milestone by successfully closing a sinus venosus ASD, a congenital heart defect, through a minimally invasive cardiology intervention.
Innovative Healthcare Initiatives in Tamil Nadu: Setting Global Standards
Greetings from Tamil Nadu, a land renowned for its rich heritage and natural beauty. As the Health and Family Welfare Minister, it is a privilege to share our state’s healthcare accomplishments at Harvard University.
Body Donation Encouraged As An Alternative To Organ Donation
The Director General of Health Services (DGHS) has issued a letter encouraging hospitals across India to promote body donation as an alternative when organ donation is not feasible. This initiative aims to address the shortage of human cadavers for medical education and research.
